Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
Drugs|December 24, 2011
Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseSuzanne M de la MonteFrontiers in Bioscience (Elite Edition)|December 29, 2011
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseSuzanne M de la MonteDrugs|December 19, 2016
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's DiseaseSuzanne M de la MonteJournal of Alzheimer'S Disease : JAD|September 18, 2023
Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes)Suzanne M de la MonteAging Health|February 9, 2016
Early intranasal insulin therapy halts progression of neurodegeneration: progress in Alzheimer's disease therapeuticsSuzanne M de la MonteEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2014
Type 3 diabetes is sporadic Alzheimer׳s disease: mini-reviewSuzanne M de la MonteAdvances in Experimental Medicine and Biology|May 8, 2019
The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 DiabetesSuzanne M de la MonteCurrent Alzheimer Research|February 15, 2012
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseSuzanne M de la MonteJournal of Alzheimer'S Disease : JAD|February 17, 2012
Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedSuzanne M de la MontePageof 17